PazePC

• CAT Number: R043255
• CAS Number: 117746-89-1
• Molecular Formula: C33H65N2O9P
• Molecular Weight: 664.86
• Purity: ≥95%
• Synonyms: (7R)-7-[(8-Carboxy-1-oxooctyl)oxy]-4-hydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-Oxide Inner Salt; ?(R)-7-[(8-Carboxy-1-oxooctyl)oxy]-4-hydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-Oxide
• Storage: -20°C
• IUPAC Name: [(2R)-2-(9-amino-9-oxononanoyl)oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
• InChI: InChI=1S/C33H65N2O9P/c1-5-6-7-8-9-10-11-12-13-14-15-18-21-24-32(37)41-28-30(29-43-45(39,40)42-27-26-35(2,3)4)44-33(38)25-22-19-16-17-20-23-31(34)36/h30H,5-29H2,1-4H3,(H2-,34,36,39,40)/t30-/m1/s1
• InChIKey: XESJPMXDDSGUSC-SSEXGKCCSA-N
• SMILES: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)N

PazePC (1-Palmitoyl-2-azetidinone-phosphatidylcholine)(CAT: R043255) is an oxidized phospholipid involved in inflammatory signaling and metabolic processes. Known as a potent PPARγ receptor agonist, it plays a crucial role in modulating lipid metabolism, glucose regulation, and immune responses. PazePC is of significant interest in research areas focusing on conditions such as atherosclerosis, diabetes, and obesity due to its ability to influence pathways related to inflammation and oxidative stress. Its dual role in both inflammation and metabolic regulation makes it a valuable target for therapeutic exploration in treating cardiovascular and metabolic disorders.